This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Teknova, a producer of life science reagents, has opened a new GMP-certified production facility which it claims will enable bioprocessing and gene therapy companies to get into the clinic faster.
When you consider the existing challenges limiting the upstream production of viral vectors, this figure becomes even more alarming. Better transfection reagents and efforts to automate the currently highly manual and inconsistent process could also make a difference, he adds.
Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot – ResearchAndMarkets.com Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot … Continue (..)
The deal will see Polyplus join the German life science group’s portfolio allowing the latter to leverage expertise in transfection reagents and plasmid DNA for gene therapy. Polyplus, based in Strasbourg, France, produces key components in the production of viral vectors used in cell and gene therapies.
C $51.51 (0 Bids)End Date: Monday Aug-24-2020 18:30:22 EDTBid now | Add to watch list Biotech365 : BioTek MicroFlo Select Microplate Reagent Dispenser BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic … Continue reading →
MIP Discovery, a developer of non-biological affinity reagents designed to accelerate the production of cell and gene therapies, has closed a Â7 million Series A financing round, led by Mercia Ventures.
$599.00End Date: Thursday Oct-8-2020 10:58:07 PDTBuy It Now for only: $599.00Buy It Now | Add to watch list Biotech365 : BioTek™ MicroFill® Microplate Dispenser AF1000A 96/384 Well Reagent u Fill BioMarketplace You want to propose your products or a Biotech … Continue reading →
Sartorius is strengthening its product portfolio for cell and gene therapies with the acquisition of a majority stake in German reagent manufacturer CellGenix.
Advances in scientific knowledge and growth in the cell and gene therapy space have led to a new and exciting era of medicine for patients, as well as a new motivation for regulators to provide clear, efficient pathways for product developers. The meeting has several goals: Discuss issues critical to early product development.
Peptide API products have become popular due to their proven pharmacological value and favourable safety profiles. The increasing demand for API peptide products is in turn increasing the demand for peptide API manufacturers who also offer contract marketing services.
Intravitreal administration consists of injecting a drug product into the space between the lens and the retina of the eye where the vitreous humor resides. Often used in pain management or analgesia, these drug products can be delivered via the spinal canal or the subarachnoid space. Intravitreal. Intralymphatic.
For example, depending on the manufacturing process for a specific human drug, the use of some specific solvents, reagents, and catalysts may trigger the formation of these possible carcinogens. First, firms should undertake risk assessments of their APIs, finished products, and products under approved or pending applications.
In molecular devices, you have a lot of processes, and they are very complex because you are dealing with different reagents and with a variety of materials. To succeed, manufacturers must understand the technical challenges that come with devices this critical and sophisticated and ensure precision is built into their production processes.
Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and controls (CMC).
Polyplus, a provider of transfection reagents, has acquired e-Zyvec, a France-based provider of DNA design and production services for tailor-made DNA vectors to expand expertise in plasmid DNA vector engineering.
Vivlion holds an exclusive license to Goethe University of Frankfurt’s proprietary 3Cs technology for the production of next generation 3Cs CRISPR/Cas gRNA libraries. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. CEO of Vivlion.
Cell therapy consumables are materials which are used in the manufacturing of cell therapies, however, do not form a part of the final product. Raw materials used for the production of cell therapies include culture media, growth factors, extracellular matrices and reagents.
The FDA’s General Approach to Regulating mHealth Products. Although mHealth has been gaining in popularity for at least the past decade, before commercializing their mHealth products, developers must determine whether the product is subject to U.S. General Wellness Products. Mobile Medical Applications.
An ACR urine reagent dipstick/strip. An absorbent pad to remove excess liquid from the reagent strip. The reagent strip is dipped into the urine sample for one second and any excess liquid is removed using the absorbent pad. A color board that allows for image recognition. “Healthy.io in the company’s press release.
Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of … Continue reading → Teknova to Join the Nasdaq Biotechnology Index Teknova to Join the Nasdaq Biotechnology Index HOLLISTER, Calif., 15, 2021 (GLOBE NEWSWIRE) — Alpha Teknova, Inc.
Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of … Continue reading → Teknova to Participate in Upcoming Investor Conferences Teknova to Participate in Upcoming Investor Conferences HOLLISTER, Calif., 16, 2021 (GLOBE NEWSWIRE) — Alpha Teknova, Inc.
Global Real Time PCR Market Research Report 2021 – ResearchAndMarkets.com Global Real Time PCR Market Research Report 2021 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Real Time PCR Market, By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical Diagnostics, (..)
Billion by 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Immunofluorescence Assay Market by Product (Reagent, Instruments, … Continue reading → The Worldwide Immunofluorescence Assay Industry is Expected to Reach $3.5
an industry pioneer in developing and commercializing diagnostic products and reagents for hematological malignancies, announced today key members of the leadership team hired to direct Invivoscribe Therapeutics, Inc., SAN DIEGO–(BUSINESS WIRE)–#invivoscribe–Invivoscribe, Inc.,
Not yet understanding how important you’d become, you entered the regulatory world without a name – the Agency simply referred to you as “home brew” products. These products are subject to the same regulatory requirements as any unapproved medical device”). It has been a long, strange trip ever since.
. Product type: Nucleic acid testing (NAT) technologies that use real-time polymerase chain reaction (RT-PCR) for detection of SARS-CoV-2. Purpose of this notice : To ensure users of certain nucleic acid testing (NAT) technologies are aware of certain aspects of the instructions for use (IFU) for all products.
Some of the variables include the chemical composition of the LNP, the manufacturing process and of course the RNA itself, whose design and production must elicit the intended therapeutic outcome.” They can’t be derived from animal products, but they are often synthesised in low purity – 60%-70% pure. weight abundance.
Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing.
This can be partly attributed to the reagents and delivery modalities that were available at the time of the trial start in 2016, leading to low editing efficiency at the target loci. The paradigm of patient-derived autologous CAR-T cell production hinders controllable or scalable manufacturing and on-time treatment for patients.
However, the conventional nucleotide library preparation process has several challenges, including requirement of huge amount of starting materials, inadequate throughput and deteriorated quality of the product. Product Competitiveness Analysis. Next Generation Sequencing (NGS) Library Preparation Kits Market – Roots Analysis.
The company manufactures proprietary components and distributes a large range of consumables for chromatography and analytical chemistry, including exclusive distribution of products from numerous top brands. With the acquisition of AIT, Calibre Scientific gains a strategic partner to continue its growth in life sciences.
The company said the problems – which also include other items like reagents and screening kits – have resulted from a switch to a new warehouse, which ironically is intended to make production quicker and more efficient through the use of automated processes. Antibody test order.
Avacta has worked with Adeptrix Inc (Beverly, MA, USA) to develop a coronavirus antigen test that combines enrichment of the sample using Affimer® reagents with the analytical power of mass-spectrometry. 28, 2021 09:19 UTC. CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.–(
.” With the panel’s authorization, Agena also aims to alleviate material shortages, enabling laboratories to accelerate testing without concerns about instrument or reagent availability. “Agena proactively sourced and secured materials to provide uninterrupted product availability to our customers.
Its scope includes Syngene providing integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical development. until 2026.
The success of COVID-19 vaccines paved the path for mRNA-based drug products. Safety, efficacy and rapid production of mRNA drives the interest in this domain. mRNA has completely revolutionized the field of medicine and significantly influenced the study and treatment of human diseases.
Through automation of manual tasks, Roche’s new solution is designed to simplify workflows and improve the productivity of lab personnel whilst also supporting the delivery of better patient care. Standardisation enables labs to do more work on fewer instruments, through consolidation of workflows, systems and reagents.
The production of such drug products requires skilled labor, stringent manufacturing protocols and specialized expertise. In addition to this, more than 95 mRNA synthesis kits, that contain reagents for the synthesis of research grade mRNAs, are currently available in the market.
It will offer chosen startups with access to investment and business guidance from Sequoia Capital China, and access to Illumina’s sequencing systems, reagents and genomics expertise. The new incubator will have two funding cycles per year, each six months long. All will be in a fully operational laboratory space in Shanghai, China.
Reagents supplier The Native Antigen Company has hired a new business development manager, Richard White , and senior product manager, Pardeep Sharda. The Consumer Healthcare Products Association has elected Sanofi’s Head of North America Consumer Healthcare Andrew Loucks to its Board of Directors.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content